TAK
Takeda Pharmaceutical Co Ltd
17.40$
-0.1%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +6.5% | -5.4% | +15.0% | -2.6% | -2.7% | -7.9% | +5.1% | +0.6% | +9.0% | -8.1% | +9.4% | – | |
| – | +10.4% | +2.1% | -0.1% | +1.9% | +5.7% | -8.3% | +0.7% | -1.2% | +45.5% | +3.3% | -28.8% | – | |
| – | +4.6% | -9.3% | +23.7% | -4.8% | -7.0% | -7.7% | +7.6% | +1.5% | -9.9% | -17.6% | +49.5% | – | |
| – | +1.9% | +4.5% | -14.0% | +4.2% | -3.1% | +26.9% | -33.4% | +12.2% | +10.5% | +11.5% | -15.8% | – | |
| – | +5.8% | +6.6% | -5.3% | -0.6% | +0.9% | +9.3% | -13.5% | -0.9% | +11.5% | +3.3% | -1.9% | – | |
| – | -16.3% | +7.5% | -2.8% | -8.7% | +10.5% | +13.0% | -28.0% | +23.5% | -29.7% | +6.4% | +23.3% | – | |
| – | – | -109.6% | – | +10.8% | -63.7% | -211.9% | – | -62.6% | +181.3% | -75.5% | +323.7% | – | |
| – | +16,485.2% | -99.5% | +18,682.2% | +14.7% | -99.7% | +59.2% | +32,352.5% | -22.4% | +51.4% | -64.7% | +43.6% | – | |
| – | – | -177.6% | – | -12.6% | -77.9% | -506.3% | – | -81.3% | +383.7% | -139.2% | – | – | |
| – | – | – | – | -34.0% | -90.6% | -263.3% | – | +51.4% | -23.1% | -193.7% | – | – | |
| – | – | -102.9% | – | -3.4% | -74.2% | -533.8% | – | -109.5% | – | -123.5% | – | – | |
| – | +27.1% | +0.9% | +49.9% | -2.1% | -49.2% | -6.1% | +142.4% | -28.0% | +44.2% | -65.4% | +113.8% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.